Results 261 to 270 of about 158,943 (347)

What Are the Limitations of Measuring Bladder Compliance, As the Sole Indicator of Future Risk to the Upper Urinary Tract and Renal Function? ICI‐RS 2025

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Maintenance of bladder filling and urinary storage at low intravesical pressures is fundamental to minimizing risk to the upper urinary tract. Bladder compliance describes the relationship between the bladder volume and the change in detrusor pressure during the filling phase of urodynamics.
Eric Rovner   +5 more
wiley   +1 more source

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang   +2 more
wiley   +1 more source

Delayed Life‐Threatening Thyroid Artery Hemorrhage After Percutaneous Transesophageal Gastro‐Tubing in Amyotrophic Lateral Sclerosis: A Case Report

open access: yesNeurology and Clinical Neuroscience, EarlyView.
ABSTRACT Percutaneous transesophageal gastro‐tubing provides enteral access when endoscopic gastrostomy is not feasible, but delayed vascular injury is seldom reported. We describe a 73‐year‐old woman with amyotrophic lateral sclerosis and prior gastrectomy who became ventilator‐dependent and underwent percutaneous transesophageal gastro‐tubing.
Yuki Yamamoto   +4 more
wiley   +1 more source

Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria. [PDF]

open access: yesAntimicrob Agents Chemother, 2018
Freire MP   +7 more
europepmc   +1 more source

A case report on the long‐term use of teduglutide in a pediatric patient with short bowel syndrome

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Short bowel syndrome (SBS) is the leading cause of intestinal failure, frequently necessitating long‐term parenteral nutrition (PN). Teduglutide (TED), a glucagon‐like peptide‐2 analog, has demonstrated efficacy in reducing PN dependence in both adults and children. However, long‐term data in pediatric populations remain limited.
Tsuyoshi Sakurai   +8 more
wiley   +1 more source

Catheter-related infections: does the spectrum of microbial causes change over time? A nationwide surveillance study. [PDF]

open access: yesBMJ Open, 2018
Buetti N   +6 more
europepmc   +1 more source

Guidelines by an ad hoc European committe for elective chronic peritoneal dialysis in pediatric patients [PDF]

open access: yes, 2001
ALONSO, A   +12 more
core  

Home - About - Disclaimer - Privacy